Dimethylglycine
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00129532)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alkyl dimethyl glycine
- c31g
- c31g
- c31g
- c31g
- c 31g
- c-31g
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03119831 | N/A | Nov 1, 2015 | University of Athens |
| NCT00130078 | Phase 3 | Sep 1, 2004 | Biosyn, FHI 360, United States Agency for International Development |
| NCT00274261 | Phase 3 | Jun 1, 2004 | Health Decisions, National Institutes of Health (NIH) |
| NCT00129532 | Phase 3 | Jan 1, 2004 | Biosyn, FHI 360, United States Agency for International Development |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biosyn | For profit | 2 | 2 | 1 | 2004 |
| FHI 360 | Academic/Hospital | 2 | 0 | 1 | 2004 |
| United States Agency for International Development | Government | 2 | 0 | 1 | 2004 |
| Health Decisions | For profit | 1 | 1 | 1 | 2004 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2004 |
| University of Athens | Academic/Hospital | 1 | 1 | 1 | 2015 |
6 organizations
Page 1 / 1